These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

58 related items for PubMed ID: 7624581

  • 21. Dynamic changes of plasma lipids and lipoproteins in patients after transient ischemic attack or minor stroke.
    Aull S, Lalouschek W, Schnider P, Sinzinger H, Uhl F, Zeiler K.
    Am J Med; 1996 Sep; 101(3):291-8. PubMed ID: 8873491
    [Abstract] [Full Text] [Related]

  • 22. Euprolactinemic Galactorrhea. Response of bioassayable prolactin to thyrotropin-releasing hormone.
    Ataya KM, Subramanian MG, Lawson DM, Gala RR.
    J Reprod Med; 1996 Mar; 41(3):156-60. PubMed ID: 8778412
    [Abstract] [Full Text] [Related]

  • 23. [Use of TRH-T for the symptomatic treatment of the pathology of the upper motoneurons and electrophysiologic evaluation of its efficacy].
    Martinelli P.
    Ann Ital Med Int; 1990 Mar; 5(3 Pt 2):262-9. PubMed ID: 2127688
    [Abstract] [Full Text] [Related]

  • 24. Analysis of the anxiolytic-like effect of TRH and the response of amygdalar TRHergic neurons in anxiety.
    Gutiérrez-Mariscal M, de Gortari P, López-Rubalcava C, Martínez A, Joseph-Bravo P.
    Psychoneuroendocrinology; 2008 Feb; 33(2):198-213. PubMed ID: 18079066
    [Abstract] [Full Text] [Related]

  • 25. Hypothalamic dysfunction in Parkinson's disease patients.
    Otake K, Oiso Y, Mitsuma T, Hirooka Y, Adachi K.
    Acta Med Hung; 1994 Feb; 50(1-2):3-13. PubMed ID: 7638039
    [Abstract] [Full Text] [Related]

  • 26. Effect of the subdermal contraceptive etonogestrel implant (Implanon) on biochemical and hormonal parameters (three years follow-up).
    Inal MM, Yildirim Y, Ertopcu K, Avci ME, Ozelmas I, Tinar S.
    Eur J Contracept Reprod Health Care; 2008 Sep; 13(3):238-42. PubMed ID: 18609340
    [Abstract] [Full Text] [Related]

  • 27. [Efficacy of TRH-T for spinocerebellar degeneration--the relation between clinical features and effect of TRH therapy].
    Waragai M, Ogawara K, Takaya Y, Hayashi M.
    Rinsho Shinkeigaku; 1997 Jul; 37(7):587-94. PubMed ID: 9396355
    [Abstract] [Full Text] [Related]

  • 28. [Changes of various hormones in successive administration of TRH-tartrate (TRH-T) (author's transl)].
    Miyoshi M, Takahara J, Miura H, Yamauchi J, Nakajima Y.
    Horumon To Rinsho; 1979 Sep; 27(9):1055-62. PubMed ID: 118831
    [No Abstract] [Full Text] [Related]

  • 29. [Protirelin tartrate. Evaluation of its effects on pyramidal-extrapyramidal rigidity in the aged during protracted treatment].
    Fonzari M, Fontanini F, Monzeglio RM, Piola P, Santiccioli L.
    Clin Ter; 1979 Sep; 138(5-6):227-32. PubMed ID: 1836171
    [Abstract] [Full Text] [Related]

  • 30. [Neuropsychologic and clinical effects of protirelin tartrate in patients with stroke sequelae].
    Fioravanti M.
    Ann Ital Med Int; 1990 Sep; 5(3 Pt 2):254-61. PubMed ID: 2127687
    [Abstract] [Full Text] [Related]

  • 31. [Patients with stroke treated with TRH-T. Evaluation of electric brain activity using traditional and computerized methods].
    Bramanti P, Di Bella P, Ricci RM, De Luca GP, De Bartolo M, Di Perri R.
    Clin Ter; 1990 Apr 15; 133(1):19-23. PubMed ID: 2140740
    [Abstract] [Full Text] [Related]

  • 32. Reversal of neurological deficits by levallorphan in patients with acute ischemic stroke.
    Handa N, Matsumoto M, Nakamura M, Yoneda S, Kimura K, Sugitani Y, Tanaka K, Takano T, Kamada T.
    J Cereb Blood Flow Metab; 1985 Sep 15; 5(3):469-72. PubMed ID: 4030925
    [Abstract] [Full Text] [Related]

  • 33. [Protirelin in the treatment of cerebrovascular disorders].
    Costa R, Cirrincione M, Chinnici M, Scaffidi A.
    Clin Ter; 1985 Sep 15; 134(3-4):205-9. PubMed ID: 2147622
    [Abstract] [Full Text] [Related]

  • 34. [The role of protirelin tartrate (TRH-T) in the rehabilitation of the post-stroke patient. XC National Congress of the Italian Society of Internal Medicine. Rome, 16-20 October 1990].
    Ann Ital Med Int; 1990 Sep 15; 5(3 Pt 2):229-80. PubMed ID: 1981835
    [No Abstract] [Full Text] [Related]

  • 35. Thyrotrophin-releasing hormone test: an adverse reaction.
    McFarland KF, Strickland AL, Metzger WT, Smith JS.
    Arch Intern Med; 1982 Jan 15; 142(1):132-3. PubMed ID: 6797360
    [Abstract] [Full Text] [Related]

  • 36. [A case of intractable epilepsy with pachygyria: the effect of TRH-T treatment].
    Takahashi H, Nakazawa T, Kanazawa C, Kaneko K, Ohtsuka C.
    No To Hattatsu; 1993 Sep 15; 25(5):465-70. PubMed ID: 8398238
    [Abstract] [Full Text] [Related]

  • 37. Continuous intravenous infusion of TRH-T: clinical, cardiovascular and endocrinological effects.
    Formisano R, Ruggieri S, Cerbo R, Lucarelli F, De Vuono G, Parmegiani M, Agnoli A, Attanasio A, Capria A, Piccolo CG.
    Acta Neurol Scand; 1991 Dec 15; 84(6):514-8. PubMed ID: 1792854
    [Abstract] [Full Text] [Related]

  • 38. [Role of lipid changes as a risk factor in cerebrovascular ischemic accidents].
    Lapetra-Peralta J, Villar-Ortiz J, Gil-Peralta A, González-Marcos JR.
    Med Clin (Barc); 1985 Apr 30; 84(16):672-3. PubMed ID: 4033243
    [No Abstract] [Full Text] [Related]

  • 39. [Thyroid hormones and lipid metabolism in the elderly].
    Canova R, Gasbarrone L, Palagi L, Mattei A, Re M, Marchionni L, Mencuccini PA, Pepe M, Clemenzia G.
    Minerva Endocrinol; 1989 Apr 30; 14(3):197-8. PubMed ID: 2622427
    [No Abstract] [Full Text] [Related]

  • 40. [Trials of 1-cysteine, TRH and 5HTP in amyotrophic lateral sclerosis].
    Akiguchi I, Kato T, Sugiyama H.
    Rinsho Shinkeigaku; 1984 Dec 30; 24(12):1270-3. PubMed ID: 6442975
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.